# How Do Health Systems and Payers Calculate Connected Care ROI in 2026?

hcco.app · October 1, 2026

> What Is the Connected Care ROI Model? The Connected Care ROI Model is a financial framework for estimating whether technology-enabled coordination...

## What Is the Connected Care ROI Model?

The Connected Care ROI Model is a financial framework for estimating whether technology-enabled coordination produces benefits greater than its total cost of ownership. It combines avoided medical spending, operational savings, revenue protection, clinical quality gains, and patient-experience effects rather than treating software implementation alone as the return. For payer and provider operations teams, the central question is not whether a platform contains AI, remote monitoring, or predictive analytics; it is whether those functions can be tied to measurable changes in utilization, workflow, adherence, access, or risk. A credible model should compare a well-defined baseline with results from a pilot, control group, or staged rollout. As of October 1, 2026, connected-care business cases increasingly need to account for data integration, clinical review, security, governance, and workflow redesign—not just license fees. The model is therefore an evidence discipline and an investment discipline, not a promise that every connected-care deployment will save money.

**Also worth reading:** [How Do You Calculate Healthcare Software ROI for Payers and Providers?](https://hcco.app/knowledge/how_do_you_calculate_healthcare_software_roi_for_payers_and_providers.php) · [How Do Health Plans Accurately Calculate Claims Adjudication Return on Investment?](https://hcco.app/knowledge/how_do_health_plans_accurately_calculate_claims_adjudication_return_on_investment.php) · [How Do Health Systems Build a Healthcare AI Cost Model That Actually Works?](https://hcco.app/knowledge/how_do_health_systems_build_a_healthcare_ai_cost_model_that_actually_works.php)

Return on investment is usually expressed as (measurable benefit - total cost) / total cost, but healthcare organizations should also report payback period, benefit-cost ratio, and the proportion of benefits independently verified. Financial benefits may be direct, such as fewer avoidable emergency department visits or lower administrative labor, or indirect, such as improved patient retention that is difficult to attribute to a single intervention. A common target for an early pilot is a benefit-cost ratio above 1.0, although a ratio above 2.0 is often more persuasive for enterprise adoption because uncertain estimates and implementation delays can erode expected value. This approach reflects a broader shift described in healthcare technology research from measuring activity volume toward measuring outcomes that matter to patients, clinicians, and operating organizations. It also explains why a dashboard showing thousands of data feeds or alerts may be operationally impressive while still producing a weak ROI case.

## Which Benefits Should the Model Measure?

The Connected Care ROI Model should separate benefits into categories so that finance leaders can distinguish cash savings from capacity improvements and clinical gains. Direct medical-cost avoidance includes reduced emergency department use, lower readmissions, shorter avoidable inpatient stays, fewer unnecessary tests, and improved management of high-risk chronic conditions. Provider benefits include reduced call-handling time, fewer manual data-entry tasks, improved referral completion, and lower patient leakage. Payer benefits may include better risk adjustment, more accurate coding, fewer denials, reduced care-management duplication, and lower total cost of care for attributed populations. Patient benefits include faster access, fewer repeated questions, better continuity, and greater ability to participate in care between visits. These categories should be translated into dollars only when there is a credible unit cost, volume estimate, and attribution method; otherwise, they should remain operational or clinical indicators.

| ROI component | Example measure | Typical evidence needed | Financial treatment |
| --- | --- | --- | --- |
| Avoided utilization | Fewer avoidable ED visits | Baseline rate, eligible population, observation period | Estimate avoided cost per event |
| Administrative efficiency | Reduced manual documentation | Time study, staffing mix, adoption data | Value only released or avoided labor time |
| Revenue protection | Improved in-network retention | Claims and network data | Use incremental net contribution margin |
| Quality improvement | Reduced readmissions or care gaps | Risk-adjusted outcomes and comparison group | Report separately unless payment is linked |
| Patient access | Shorter time to appointment | Scheduling and access logs | Treat as capacity benefit until converted to demand or margin |

A useful distinction is between gross benefit and realized benefit. If software reduces ten minutes of documentation per patient encounter, the gross labor value may be calculated from loaded hourly cost, but the realized value is only realized if staffing schedules, workload, or service capacity actually change. Similarly, a program may identify high-risk patients earlier without reducing spending during the measurement window; that is valuable learning, but it is not automatically a financial return. Baxter’s discussion of measuring ROI in healthcare emphasizes the need to connect connected-care interventions to concrete operational and economic outcomes. The best models present several benefit scenarios—conservative, expected, and upside—rather than presenting one optimistic estimate as certain.

## How Do You Build a Baseline and Calculate the Return?

Start by defining the population, intervention, and period before examining favorable results. For example, a heart-failure remote monitoring program should specify adults discharged with a particular diagnosis, the types of devices and alerts used, the care-team response protocol, and the comparison population. Capture at least 12 months of baseline data when available, then use a 3-, 6-, or 12-month post-launch measurement period depending on the outcome and operational cycle. Risk adjustment is necessary because enrolled patients may differ from non-enrolled patients in age, illness severity, prior utilization, and social needs. Difference-in-differences, matched cohorts, or phased rollouts can provide stronger evidence than a simple before-and-after comparison, although no observational method eliminates every source of bias.

The calculation should use incremental results, not total population performance. If an intervention group has 100 ED visits before and 75 after, while a comparable group falls from 100 to 90, the connected-care program may be associated with 15 avoided visits, not 25. Multiply that incremental volume by an approved cost per event, then subtract program costs and any implementation expenses. Program costs generally include subscription fees, device costs, connectivity, implementation services, integration work, training, clinical staffing, security review, and ongoing monitoring. The model should also state whether benefits are gross or net of reimbursement changes, because a provider can reduce a service line’s utilization without recovering the lost revenue when payment is fee-for-service. For a payer, savings may be shared through capitation or value-based contracts; for a provider, the financial benefit may appear as capacity release rather than immediate cash. These distinctions are more informative than a single ROI percentage.

## What Is the Practical Implementation Process?

The practical process begins with selecting one business problem with an accountable owner, such as post-discharge follow-up, specialty access, or high-risk population management. Define a baseline dashboard with 5 to 12 months of history, select no more than three primary outcomes, and document the interventions required to produce them. A typical sequence is discovery and data validation, workflow design, configuration, integration, training, pilot launch, measurement, and expansion decision. During the pilot, monitor not only financial indicators but also alert volume, response time, override rates, staff satisfaction, patient engagement, and unintended effects. A program that creates more alerts than the team can review can increase workload while appearing to improve care. The rollout should therefore include stop conditions and predefined rules for modifying or ending an ineffective workflow.

For a credible 90-day evaluation, the first 30 days can be used to establish baselines, confirm data quality, and train staff; days 31–60 can test workflows with a limited cohort; and days 61–90 can measure early utilization and operational signals. Longer medical outcomes usually require 6 to 12 months, and chronic-care readmission or total-cost effects may take even longer. The finance team should validate costs, the clinical team should validate appropriateness, operations should validate feasibility, and compliance or privacy teams should validate governance. This cross-functional review reduces the risk of counting a displaced task as a saving or treating a clinical improvement as guaranteed cost avoidance. A pilot is not automatically a failed deployment if it produces high-quality evidence but a weak return; it may instead indicate that the wrong use case, population, or response model was selected.

## How Do Connected Care Platforms Compare with Alternatives?

Connected-care platforms vary in how they create value. A general workflow platform may integrate records, messaging, referrals, and scheduling, making it appropriate when the immediate problem is fragmented operations. Remote patient monitoring is better suited to collecting device or patient-reported data and triggering follow-up, provided the care team can act on the information. Predictive analytics can prioritize risk, but its value depends on accurate data, calibrated thresholds, and an effective intervention. Staff augmentation may produce near-term value through call-center support or care-manager workflow, while full clinical programs can address long-term utilization but require more time and expense. The right comparison is usually among operating models, not among vendors.

| Feature | Connected-care platform | Basic telehealth | Manual care coordination | Enterprise analytics |
| --- | --- | --- | --- | --- |
| Primary value | Integrated data and coordinated action | Convenient synchronous or asynchronous access | Relationship-based outreach and navigation | Forecasting, reporting, and risk identification |
| Typical ROI horizon | 6–18 months | 1–6 months | 3–12 months | 3–12 months for reporting; longer for avoided cost |
| Main cost | Platform, integration, configuration, and clinical operations | Platform, licenses, training, and device support | Staff time, training, and turnover | Software, data engineering, governance, and administration |
| Best suited to | Multi-step care journeys | Simple access and follow-up | Small or relationship-intensive programs | Population insight and resource planning |
| Main limitation | Benefits depend on adoption and workflow | Can add encounters without reducing avoidable care | Difficult to scale consistently | Prediction does not itself change care |

Basic telehealth may have a faster and lower-cost path to access improvement, but it does not automatically reduce hospital utilization. Manual coordination can be highly effective for selected populations, but its economics are often constrained by staff capacity and inconsistent documentation. Enterprise analytics can identify high-cost patterns or forecast demand, yet a prediction without an intervention may not produce savings. A connected-care ROI model should therefore compare each option against the business objective, the current process, and the cost of doing nothing. It should not assume that adding technology to an unchanged workflow will generate measurable value.

## What Costs and Pricing Thresholds Should Buyers Consider?

Pricing is rarely comparable across connected-care vendors because fees may cover software, devices, implementation, clinical services, messaging, analytics, and support in different combinations. Buyers should request a three-year total-cost-of-ownership proposal that separates recurring subscription and per-patient fees from one-time integration, training, device, security, and change-management costs. As a planning—not vendor quote—assumption, a narrowly scoped pilot may cost tens of thousands of dollars, while an enterprise deployment involving multiple systems, device fleets, clinical pathways, and dedicated staffing can reach six or seven figures. These are ranges rather than market prices; actual cost depends on scope, data interfaces, security requirements, device type, staffing model, and contract terms. The date and context matter: as of October 1, 2026, buyers should expect greater scrutiny of AI governance, data portability, interoperability, and total cost than a simple per-seat price suggests.

A practical approval threshold can be expressed in three ways. First, require an expected benefit-cost ratio of at least 1.5 for a limited pilot and at least 2.0 for expansion when benefits include uncertain long-term medical savings. Second, require a payback period shorter than the organization’s acceptable investment horizon, such as 12–24 months for operational improvements and 24–36 months for broader clinical programs. Third, require a confidence range that identifies what could make the business case fail. These thresholds are organizational guidance, not universal rules, and they should be adjusted for nonprofit constraints, payer contract structures, and the strategic value of quality or access improvements. A vendor claiming a 400% return, such as the chatbot example cited in the research context, should be treated as a case-specific claim until the denominator, attribution method, time period, implementation cost, and comparison group are disclosed.

## What Mistakes Commonly Produce Inflated ROI?

The most common mistake is counting gross activity as net benefit. High patient engagement, thousands of messages, or a large number of generated alerts may show that the system is being used, but they do not prove lower spending or better outcomes. Another error is comparing a selected pilot group with a historical average without controlling for seasonality, case mix, referral patterns, or concurrent quality initiatives. Teams also frequently omit staff time, device replacement, integration maintenance, security controls, and patient support from costs. In some programs, the vendor’s ROI calculation uses a list price for avoided services, while the actual organization receives only a small percentage of that amount through a value-based contract.

A fourth mistake is treating a clinical association as proof that the technology caused the improvement. Readmissions can fall because of a broader care transition initiative, payer policy, or changes in coding, not because of a connected-care feature alone. Fifth, organizations may launch a program before confirming that clinicians have enough capacity to respond. This produces alert fatigue and can damage trust. Sixth, buyers may assume that AI accuracy is synonymous with financial accuracy; the model may be accurate at ranking risk while still lacking the intervention needed to change behavior. A defensible model documents every assumption, labels measured versus estimated values, and reports negative or neutral results. Independent validation or finance review is valuable when expected savings are material, particularly above $500,000 or when the program relies on complex causal claims.

## When Should a Healthcare Organization Act, and When Should It Wait?

Organizations should act when a measurable workflow problem exists, a baseline can be established, an accountable owner is assigned, and the intervention is capable of changing an outcome within a realistic measurement period. Good initial candidates include post-discharge outreach, referral completion, high-risk patient engagement, appointment access, and avoidable utilization where the organization already has a credible response pathway. Acting sooner is appropriate when contracts, staffing, or partner incentives make delay costly, provided the first deployment remains bounded and measurable. A 90-day operational pilot can be reasonable for workflow and access questions; a 6–12 month evaluation is more appropriate for chronic-care utilization and total-cost-of-care questions.

Waiting may be sensible when data definitions are unstable, the clinical workflow is still changing, or no one owns the response process. It is also wise to defer a broad rollout when the expected benefit depends almost entirely on unverified AI predictions or when integration would duplicate an existing platform. Before proceeding, organizations should ask whether they can compare the program with a credible alternative and whether they can stop it without losing sunk investment. Connected-care spending is not automatically wasteful, but technology without a measurable use case transfers financial risk to the organization. The strongest decision rule is to fund the next stage only when the evidence exceeds a predefined threshold and the next stage itself has a clear learning objective.

## What Does a Decision-Grade Connected Care Business Case Look Like?\n

A decision-grade business case combines financial, operational, clinical, and strategic evidence in one coherent story. It identifies the eligible population, baseline performance, intervention, comparison method, time horizon, owners, and total cost. It separates verified benefits from modeled benefits and includes sensitivity analysis for adoption, staffing response, event cost, and attribution. For example, a payer might model 10%, 20%, and 30% reductions in a specific avoidable-utilization measure rather than presenting the most favorable estimate as the expected result. A provider might show how reduced documentation time creates appointment capacity, then distinguish capacity value from immediate labor savings. The final decision should explain what will be measured next, when the organization will review results, and what threshold triggers expansion, redesign, or termination.

The Connected Care ROI Model is therefore not a single formula but a repeatable way to test whether connected-care investment creates value under real operating conditions. It recognizes that payer and provider economics differ, that clinical outcomes may improve before financial returns appear, and that implementation quality strongly affects results. By using conservative assumptions and transparent evidence, organizations can compare options without confusing technology adoption with value. For HCCO’s audience, the relevant message is disciplined: connected-care software should earn expansion through measurable cost containment, better coordination, or defensible operating improvements—not through a claim that innovation alone guarantees ROI.

## Quick answers

### What is a good connected-care ROI for a first pilot?

A benefit-cost ratio above 1.0 can justify continuation of a limited pilot, while 1.5–2.0 or more is generally a stronger expansion case. The appropriate threshold depends on the cost of implementation, the certainty of benefits, and whether the organization values quality or access improvements beyond immediate cash savings.

### How long does it take to measure connected-care ROI?

Operational improvements such as call handling or referral completion may be measurable within 90 days. Medical utilization, readmissions, or total-cost effects commonly require at least 6–12 months, and some chronic-care outcomes need longer periods and comparison groups.

### Should connected-care ROI include staff productivity gains?

Yes, but productivity should be reported honestly as capacity released, labor avoided, or improved service throughput unless staffing and schedules actually change. Ten minutes saved per encounter does not necessarily become cash savings if the saved time is absorbed without reducing cost or increasing productive capacity.

### Can AI be used in the Connected Care ROI Model?

AI can help prioritize patients, summarize information, or identify operational risks, but its financial value must be tied to an action that changes results. Prediction accuracy alone does not establish ROI; the model should include response time, adoption, intervention effectiveness, and the cost of reviewing AI outputs.

### Is telehealth cheaper than a connected-care platform?

Telehealth may have lower implementation costs for a narrow access use case, while a connected-care platform can address referrals, monitoring, communication, and care-team workflows across a broader pathway. The correct comparison is based on total cost, required integrations, staffing, expected utilization reduction, and the duration of measurable benefits.

Canonical: https://hcco.app/knowledge/how_do_health_systems_and_payers_calculate_connected_care_roi_in_2026.php
Markdown: https://hcco.app/knowledge/how_do_health_systems_and_payers_calculate_connected_care_roi_in_2026.php/index.md